'Tuberculosis-resistant' cattle developed in China: Report

Image
Press Trust of India Beijing
Last Updated : Feb 01 2017 | 8:02 PM IST
A tuberculosis-resistant cattle breed has been developed by Chinese scientists who say this would provide an avenue to create a genome editing system for agricultural applications.
Twenty calves were born, of which 11 survived for more than three months, BBC reported.
Bovine TB is a risk to cattle in many countries, including parts of the UK, Africa and Asia.
Researchers in China used a genome editing tool to change the genetic code of cattle.
They say the technology could have widespread uses in agriculture.
A team from the College of Veterinary Medicine, Northwest A&F University in Shaanxi, China, altered a gene involved in fighting infection.
"The resulting transgenic cattle exhibited increased resistance to M bovis (bovine TB) infection," they said.
"Our study provides an avenue to develop the CRISPR/Cas9 system for agricultural applications."
CRISPR-Cas9 is a genome editing tool.
Scientists in China have previously inserted a mouse gene into cattle in an attempt to boost protection against TB.
The latest research, published in the journal, Genome Biology, used the new genome editing tool, which is more precise, the report said.
Tests on resistance to TB were carried out on blood samples taken from the cloned animals.
It is not clear what would happen if the transgenic cattle were exposed to tuberculosis in normal conditions.
Prof Ian McConnell, emeritus professor of veterinary science at the University of Cambridge, said TB in cattle is a complex disease.
"Although it is a thorough and novel paper on using gene technology in transgenic cattle at this stage I doubt if the research will have any application to prevention of TB in cattle using transgenic technology," he said.
And Prof Alan Archibald, head of genetics and genomics at The Roslin Institute, University of Edinburgh, added: "I was not convinced that the authors had demonstrated that the edited calves were resistant - there was no pathology reported for the edited or control animals.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 01 2017 | 8:02 PM IST

Next Story